Curr Psychiatry Rep
December 2024
Purpose Of Review: Through an overview of invasive lobular carcinoma (ILC), this review highlights the unique complexities the diagnosis and treatment of this disease represents, followed by psychological considerations for both patients and providers. Perspectives from members of the multidisciplinary treatment team are included.
Recent Findings: A cancer diagnosis can be difficult for patients and their families and can also have a significant impact on the treatment team.
Metastatic castrate-resistant prostate cancer (mCRPC) is a genetically and phenotypically heterogeneous cancer where advancements are needed in biomarker discovery and targeted therapy. A critical and often effective component of treatment includes taxanes. We perform a high-throughput screen across a cohort of 30 diverse patient-derived castrate-resistant prostate cancer (CRPC) organoids to a library of 78 drugs.
View Article and Find Full Text PDFObjective: This non-interventional, prospective, single-center study aimed to develop a technique to measure ruxolitinib (RUX) concentrations and provide preliminary data on the distribution of plasma drug levels in patients with steroid refractory (SR) GvHD.
Methods: Between April 2023 and May 2024, we analyzed 48 blood samples from 29 patients with SR-GvHD.
Results: Median individual plasma concentrations varied across different RUX doses and largely overlapped: 39.
Background: Workplace violence significantly affects registered nurses, contributing to burnout and intention to leave.
Methods: The Michigan Nurses Study conducted surveys in 2022 and 2023, examining the prevalence of verbal, physical, and sexual violence, and coworker bullying. Personal and workplace factors associated with reporting any violent event were examined using multivariable logistic regression.